Diagnosing Xeroderma pigmentosum group C by immunohistochemistry

American Journal of Dermatopathology

Volumn 32, Issue 2, 2010, Pages 109-117

  De Feraudy, Sébastien ^a   Boubakour Azzouz, Imenne ^a   Fraitag, Sylvie ^b   Berneburg, Mark ^c   Chan, Loretta ^d   Chew, Kevin ^d,g   Clericuzio, Carol L ^e   Cunningham, Bari ^f   Tope, Whitney D ^a,h   Cleaver, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Genomic Health Inc   (United States)

^h NONE   (United States)

Author keywords

Diagnosis; Immunohistochemistry; Skin cancer; Xeroderma pigmentosum; XPC

Indexed keywords

KI 67 ANTIGEN; PARAFFIN; PROTEIN P35; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 77949945101     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181af0a5e     Document Type: Article

References (35)

1. Cleaver JE. Defective repair replication in xeroderma pigmentosum. Nature. 1968;218:652-656.
2. Bootsma D, Kraemer KH, Cleaver JE, et al. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Human Cancer. New York, NY: McGraw-Hill; 1998:245-274.
3. Cleaver JE, Crowley E. UV damage, DNA repair and skin carcinogenesis. Front Bioscience. 2002;7:d1024-d1043.
4. Thompson LH. Nucleotide excision repair: its relation to human disease. In: Nickoloff JA, Hoekstra M, eds. DNA Repair in Higher Eukaryotes. Vol 2. Totowa, NJ: Humana Press; 1998:335-393.
5. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular and neurological abnormalities in 830 published cases. Arch Dermatol. 1987;123:241-250.
6. Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer. 2005;5:564-573.
7. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411:366-374.
8. Reardon JT, Sancar A. Nucleotide excision repair. Prog Nucleic Acid Res Mol Biol. 2005;79:183-235.
9. Coin F, Oksenych V, Egly JM. Distinct roles for the XPB/p52 and XPD/ p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Mol Cell. 2007;26:245-256.
10. Oh KS, Imoto K, Boyle J, et al. Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UVinduced DNA damage. DNA Repair (Amst). 2007;6:1359-1370.
11. Ogi T, Lehmann A. The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair. Nat Cell Biol. 2006;8: 640-642.
12. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991;88:10124-10128.
13. Nataraj AJ, Trent JC, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem Photobiol. 1995;62:165-177.
14. Dumaz N, Drougard C, Sarasin A, et al. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1993;90: 10519-10533.
15. Cleaver JE. The biology of xeroderma pigmentosum: lessons learned to explain the development of melanoma. In: Hearing VJ, Leong SPL, eds. Melanocytes to Melanoma: The Progression to Malignancy. Vol 16. Totowa, NJ: Humana Press; 2005.
16. Cleaver JE, Feeney L, Tang JY, et al. Xeroderma pigmentosum group C in an isolated region of Guatemala. J Invest Dermatol. 2007;127:493-496.
17. Nishigori C, Zghal M, Yagi T, et al. High prevalence of point mutations in exon 6 of xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia. Am J Hum Genet. 1993;53:1001-1006.
18. Satokata I, Tanaka K, Yuba S, et al. Identification of splicing mutations of the last nucleotide of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum. Mutat Res. 1992;273:203-212.
19. Kleijer WJ, Laugel V, Berneburg M, et al. Incidence of DNA repair deficiency disorders in Western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst). 2008;7:744-750.
20. Khan SG, Metter EJ, Tarone RE, et al. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis. 2000;21:1821-1825.
21. Khan SG, Muniz-Medina V, Shahlavi T, et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002;30:3624-3631.
22. Khan SG, Metin A, Gozukara E, et al. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet. 2004;13:343-352.
23. Chavanne F, Broughton BC, Pietra D, et al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 2000;60:1974-1982.
24. Rivera-Begeman A, McDaniel LD, Schultz RA, et al. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with xeroderma pigmentosum: a case report and review of the genetic variants reported in XPC. DNA Repair (Amst). 2007;6:100-114.
25. Porreca GJ, Zhang K, Li JB, et al. Multiplex amplification of large sets of human exons. Nat Methods. 2007;4:931-936.
26. Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a seven year study. Br J Dermatol. 2005;152: 545-551.
27. Khan SG, Oh KS, Shahlavi T, et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis. 2006;27:84-94.
28. Bashyam MD. Studies on nonsense mediated decay reveal novel therapeutic options for genetic diseases. Recent Pat DNA Gene Seq. 2009;3:7-15.
29. Emmert S, Slor H, Busch DB, et al. Relationship of neurologic degeneration to genotype in xeroderma pigmentosum group G patients. J Invest Dermatol. 2002;118:972-982.
30. Broughton BC, Cordonnier A, Kleijer WJ, et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci U S A. 2002;99:815-820.
31. Oh KS, Khan SG, Jaspers NG, et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat. 2006;27:1092-1103.
32. Taylor EM, Broughton BC, Botta E, et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci U S A. 1997;94: 8658-8663.
33. Botta E, Nardo T, Lehmann AR, et al. Reduced level of the repair/ transcription factor TFIIH in trichothiodystrophy. Hum Mol Genet. 2002; 11:2919-2928.
34. Botta E, Nardo T, Broughton BC, et al. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am J Hum Genet. 1998;63:1036-1048.
35. Cleaver JE, Cortes F, Lutze LH, et al. Unique DNA repair properties of a xeroderma pigmentosum revertant. Mol Cell Biol. 1987;7: 3353-3357.